10-Q/A

PERIOD ENDING SEPTEMBER 30, 2002

Company: Oncotelic Therapeutics, Inc.
Filed: November 14, 2002
Period of Report: September 30, 2002
Accession Number: 0000908259-02-000014

View Document ↗ View on SEC.gov ↗